Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Post-Dural Puncture Headache × Aprepitant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Vomiting 8 Nausea 4 Lymphoma 3 Breast Neoplasms 3 Neoplasms 2 Leukemia 2 Uterine Neoplasms 1 Thyroid Neoplasms 1 Sezary Syndrome 1 Pruritus 1 Post-Dural Puncture Headache 1 Ovarian Neoplasms 1 Hematologic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02347878 2015-01-27

Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)

Sun Yat-sen University

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Post-Dural Puncture Headache

Data powered by HemOnc (CC BY 4.0) Colophon ⚡